Evidence map›Paper›PMID 41745349›Full record

ArticleJournal of cardiovascular development and disease2026

The Left Axillary Artery as an Alternative Inflow Source in Minimally Invasive Coronary Artery Bypass Grafting: Safety, Feasibility, and Mid-Term Outcomes.

Jian Song, Tong Ding, Rui Li, Yichen Gong, Ruitao Zhang, Yuanhao Fu, Luyu Meng, Song Wu, Zhongqi Cui, Ya Wu and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jian SongDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Tong DingDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Rui LiDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Yichen GongDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Ruitao ZhangDepartment of Cardiology, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Yuanhao FuDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Luyu MengDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Song WuDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Zhongqi CuiDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Ya WuDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Chen YangDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Ming CuiDepartment of Cardiology, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Yunpeng LingDepartment of Cardiac Surgery, Peking University Third Hospital, Peking University Health Science Center, Beijing 100191, China.ORCID 0000-0003-3003-1724

Funding

National Natural Science Foundation of China 82300293Natural Science Foundation of Shandong Provincial ZR2024QH366Peking University Third Hospital BYSYDL2022012Peking University Third Hospital BYSYDL2025002Peking University Third Hospital BYSYZD2022039Peking University Third Hospital BYSYZD2023015
6 · The paper itself

Abstract

objectiveThe objective of this study is to evaluate the safety, feasibility, and mid-term outcomes of using the left axillary artery (AXA) as an alternative inflow source for the proximal anastomosis of the saphenous vein graft (SVG) in MICS-CABG, focusing on intraoperative graft haemodynamics, early patency, and clinical outcomes.

methodsWe retrospectively analyzed consecutive patients who underwent MICS-CABG between April 2020 and August 2025 at a single center. Patients were divided into two groups based on the inflow source: the ascending aorta (n = 292) or the left axillary artery (n = 90). After propensity score matching, 80 matched pairs were analyzed. Intraoperative graft haemodynamics were assessed. Early graft patency was evaluated using coronary angiography or CT angiography. Mid-term outcomes, including overall survival and major adverse cardiac and cerebrovascular events (MACCEs), were compared between groups.

resultsBoth groups demonstrated comparable intraoperative hemodynamic performance. The AXA group demonstrated an early graft occlusion rate comparable to that of the AOR group (1.32% vs. 3.16%, RR = 0.42, 95% CI = 0.08-2.11, and

conclusionsThe left axillary artery is a safe and feasible alternative inflow source in MICS-CABG. This approach provides acceptable intraoperative flow dynamics, early patency, and mid-term outcomes to conventional ascending aortic inflow.

Indexed as

axillary arterygraft inflow sourceMICS-CABGproximal anastomosissaphenous vein graft

Identifiers

PMID41745349
PMCPMC12940880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.